Navigation Links
Protein signal is crucial for accurate control of insect size
Date:5/4/2012

HEIDELBERG, 4 May 2012 Two independent groups of researchers have identified a hormone that is responsible for keeping the growth and development of insects on track. The results, which are reported in the journal Science, suggest that Dilp8 provides an important signal to slow body growth and delay insect development. This braking effect is an essential part of normal development since it allows sufficient time for tissues to form and the correct body size, proportions and symmetry to be achieved.

"The important question about the control of animal size is knowing when to stop," said EMBO Member Maria Dominguez, lead author of one of the papers and Professor at the Institute of Neurosciences in Alicante, Spain. "To achieve the required precision in the control of growth, organs within the body of an insect must be capable of sensing their own size and communicating their dimensions to other organs in the body and to the endocrine system." She added: "Our work with Drosophila suggests that growing organs and tissues produce a secreted peptide known as Dilp8. This hormone coordinates the growth rate of different organs in the body and is capable of delaying important developmental steps such as metamorphosis. In healthy flies, this additional time is essential to ensure that functional tissues are established and for organs to reach normal size. It also ensures that organs maintain perfect bilateral symmetry."

Dominguez and collaborators examined tumours in the eye discs of Drosophila, parts of the insect body that go on to generate fully formed eyes in mature adult flies. Developing flies often adjust growth and the timing of metamorphosis to compensate for the disturbance induced by tumours or injury. The researchers wanted to investigate if a shared molecular signal was responsible for these observations. "Our work identifies Dilp8 as a signal that communicates the growth status of tissues as well as local responses to recovery from injury and cancer," said Dominguez.

EMBO Member Pierre Lopold and collaborators from the Institute of Biology Valrose at the University of Nice, France, identified the same protein using a different experimental approach. "We used a genome-wide RNA interference approach to look for Drosophila gene candidates that might be involved in coupling growth with the timing of development. Out of 11,000 genes that we tested in our genetic screen, only one was able, upon silencing, to rescue the delay in development induced by conditions that perturb tissue growth. This candidate gene corresponded to dilp8, which is exactly same gene identified by Dominguez and collaborators."

The expression of the dilp8 gene reduces tissue growth, which suggests that in addition to its role in preventing the hormonal induction of metamorphosis, dilp8 could act by slowing the growth of healthy tissues to stay synchronized with slow-growing tissue.

Until now, little information at the molecular level has been available about how organ growth is monitored and coordinated with the timing of development in insects and other complex organisms. Dilp8 appears to be part of the molecular machinery that helps tissues to grow and develop at the right pace.


'/>"/>

Contact: Barry Whyte
barry.whyte@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert  

Related biology news :

1. Key proteins newly discovered form and function may provide novel cancer treatment target
2. In protein folding, internal friction may play a more significant role than previously thought
3. High levels of TRAIL protein in breast milk might contribute to anticancer activity
4. New study finds a protein combination is best to consume post-workout for building muscle
5. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
6. Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
7. Newly found protein helps cells build tissues
8. Plant research reveals new role for gene silencing protein
9. Protein jailbreak helps breast cancer cells live
10. New hope for treating Alzheimers Disease: A role for the FKBP52 protein
11. The Japanese traditional therapy, honokiol, blocks key protein in inflammatory brain damage
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Protein signal is crucial for accurate control of insect size
(Date:2/10/2017)... , Feb 10, 2017 ... new report "Personalized Medicine - Scientific and Commercial Aspects" ... ... personalized medicine. Diagnosis is integrated with therapy for selection of ... on early detection and prevention of disease in modern medicine. ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 ... Driven largely by the confluence of organizations, desires ... distaste for knowledge-based systems (password and challenge questions), ... industrial, and government systems. The market is driven ... a demarcation between consumer and enterprise uses cases, ...
(Date:2/6/2017)... 6, 2017 According to Acuity Market ... border authorities to continue to embrace biometric and ... 2143 Automated Border Control (ABC) eGates and 1436 ... more than 163 ports of entry across the ... achieving a combined CAGR of 37%. APC Kiosks ...
Breaking Biology News(10 mins):
(Date:2/24/2017)...  VWR Corporation (NASDAQ: VWR), the leading global independent provider ... today reported its financial results for the fourth quarter and ... 4Q16 record quarterly net sales of $1.13 ... basis. 4Q16 EMEA-APAC segment net ... the Americas net sales increased 2.5%, or down 0.9% on ...
(Date:2/23/2017)... NEW YORK , Feb. 23, ... , a leading digital health company, and ... of telemedicine and remote patient monitoring, announce they ... reimbursements.  DN Telehealth maximizes collaboration ... real-time, extending consultations beyond a physical clinical setting ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
Breaking Biology Technology: